At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 59 enrolled
Drug / intervention
Enalapril Maleate +1 moredrug
Likely dose
Enalapril Maleate 5 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Prophylactic Treatment With Enalapril Maleate on Arterial Stiffness in Rheumatoid Arthritis Patients.
In Brief
A Phase 2 clinical trial evaluating Enalapril Maleate and Placebo for Rheumatoid Arthritis. Completed, enrolled 59 participants across 1 site.
Detailed Summary
This study evaluates the effect in artery stiffness of enalapril maleate in Rheumatoid Arthritis women patients. Half of participants will receive 5 mg enalapril maleate every 12 hrs, while the other half will receive a placebo.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRheumatoid Arthritis
CountriesMexico
Collaborators--
Timeline
Phase 2CompletedFinished
2017201820192020202120222023202420252026
Enrollment StartFeb 2017
Primary CompletionDec 2017
Study CompletionFeb 2018
First PostedSep 2018
TodayJul 2026
First PostedSep 12, 2018
Enrollment StartFeb 13, 2017
Primary CompletionDec 8, 2017
Study CompletionFeb 19, 2018
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 7.8 years ago
Interventions
Enalapril Maleatedrug
Enalapril Maleate 5 mg tablet, every 12 hrs for 90 days.
Placebodrug
Placebo 5 mg tablet, every 12 hrs for 90 days.